arrow
J

Jiani C. Yin

nanjing geneseeq technology inc.
H指数:16
被引数:1,105

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cardiac magnetic resonance assessment of long-term cardiac function after early recombinant staphylokinase thrombolysis before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction patients

对ST段抬高型心肌梗死患者早期重组葡萄球菌激肽原溶栓治疗前进行原发经皮冠状动脉介入治疗前长期心脏功能的磁共振评估

2026-01-010
PRE
The Oncologist, 2025, Vol, XX, Issue XX Predictive role of ARID1A and B2M mutations and the antigen presentation pathway in the efficacy of definitive chemoradiotherapy for cervical cancer

《肿瘤医师》, 2025年, 卷XX, 期XX ARID1A和B2M基因突变及抗原提呈通路在宫颈癌根治性放化疗疗效中的预测作用

2025-06-010
OAAI
Improvements in Hematological Parameters and Quality of Life (QOL) with Elritercept (KER-050): Results from an Ongoing Phase 2 Trial in Participants with Lower-Risk (LR) Myelodysplastic Neoplasms (MDS)

在Elritercept(KER-050)治疗下,血液学参数和生活质量(QOL)的改善:来自一项针对低风险(LR)骨髓异常增生性肿瘤(MDS)患者正在进行的2期试验的结果

BLOOD
IF23.1
2024-11-050
PRE